Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Berg

Showing results (201-210 of 547) with videos related to

Pageof 55
Sort By:
Neuroscience Letters|August 29, 2006
Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigraNilgün Akbas, Helmine Hochstrasser, Joelle Deplazes, et al.
Journal of Alzheimer'S Disease : JAD|May 20, 2011
Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementiasWalter Maetzler, Daniela Berg, Matthis Synofzik, et al.
Plos One|October 4, 2011
Discovery of new molecular subtypes in oesophageal adenocarcinomaDaniela Berg, Claudia Wolff, Rupert Langer, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 22, 2015
Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian CohortToomas Toomsoo, Inga Liepelt-Scarfone, Riina Kerner, et al.
Psychiatry Research. Neuroimaging|September 3, 2017
Prevalence of depressive symptoms and their association with brainstem raphe echogenicity in patients with Parkinson's disease and non-PD controlsToomas Toomsoo, René Randver, Inga Liepelt-Scarfone, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2010
Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's diseaseSimone van de Loo, Uwe Walter, Stefanie Behnke, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 10, 2005
Functional relevance of ceruloplasmin mutations in Parkinson's diseaseHelmine Hochstrasser, Jürgen Tomiuk, Uwe Walter, et al.
Sensors (Basel, Switzerland)|April 3, 2021
Step Length Is a Promising Progression Marker in Parkinson's DiseaseJulius Welzel, David Wendtland, Elke Warmerdam, et al.
The Journal of Pathology|December 3, 2010
Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysisClaudia Wolff, Katharina Malinowsky, Daniela Berg, et al.
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body diseaseWalter Maetzler, Velichka Stoycheva, Benjamin Schmid, et al.
Pageof 55

Showing results (201-210 of 547) with videos related to

Sort By:
Pageof 55
Neuroscience Letters|August 29, 2006
Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigraNilgün Akbas, Helmine Hochstrasser, Joelle Deplazes, et al.
Journal of Alzheimer'S Disease : JAD|May 20, 2011
Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementiasWalter Maetzler, Daniela Berg, Matthis Synofzik, et al.
Plos One|October 4, 2011
Discovery of new molecular subtypes in oesophageal adenocarcinomaDaniela Berg, Claudia Wolff, Rupert Langer, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 22, 2015
Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian CohortToomas Toomsoo, Inga Liepelt-Scarfone, Riina Kerner, et al.
Psychiatry Research. Neuroimaging|September 3, 2017
Prevalence of depressive symptoms and their association with brainstem raphe echogenicity in patients with Parkinson's disease and non-PD controlsToomas Toomsoo, René Randver, Inga Liepelt-Scarfone, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2010
Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's diseaseSimone van de Loo, Uwe Walter, Stefanie Behnke, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 10, 2005
Functional relevance of ceruloplasmin mutations in Parkinson's diseaseHelmine Hochstrasser, Jürgen Tomiuk, Uwe Walter, et al.
Sensors (Basel, Switzerland)|April 3, 2021
Step Length Is a Promising Progression Marker in Parkinson's DiseaseJulius Welzel, David Wendtland, Elke Warmerdam, et al.
The Journal of Pathology|December 3, 2010
Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysisClaudia Wolff, Katharina Malinowsky, Daniela Berg, et al.
Journal of Alzheimer'S Disease : JAD|September 23, 2010
Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body diseaseWalter Maetzler, Velichka Stoycheva, Benjamin Schmid, et al.
Pageof 55